Author/Authors :
Hassani, Valiollah Pain Research Center - Iran University of Medical Sciences - Tehran - Iran , Amniati, Saied Pain Research Center - Iran University of Medical Sciences - Tehran - Iran , Kashaninasab, Fatemeh Mental Health Research Center - Tehran Institute of Psychiatry - Iran University of Medical Sciences - Tehran - Iran , Niakan, Mohammad Trauma and Injury Research Center - Critical Care Medicine Department - Iran University of Medical Sciences - Tehran - Iran , Moradi Moghadam, Omid Trauma and Injury Research Center - Critical Care Medicine Department - Iran University of Medical Sciences - Tehran - Iran , Jafarian, Ali Akbar Pain Research Center - Iran University of Medical Sciences - Tehran - Iran , Farahmand Rad, Reza Pain Research Center - Iran University of Medical Sciences - Tehran - Iran , Sehat-Kashani, Saloome Pain Research Center - Iran University of Medical Sciences - Tehran - Iran , Habibi, Azadeh Pain Research Center - Iran University of Medical Sciences - Tehran - Iran
Abstract :
Electroconvulsive therapy (ECT) was first experienced in 1938 and had been conducting without anesthesia for 30 years. In this
study, the most common indication for ECT was mood disorder (major depressive disorder and bipolar I disorder). We introduce a
patient with a history of COVID-19 and suicide who required emergency ECT. Electroconvulsive therapy can be life-saving in patients
with suicide history or catatonic schizophrenia. Health workers are at the front line of the COVID-19 outbreak control and must
follow health instructions. Aerosol-producing procedures such as suction in anesthesia for ECT may facilitate the transmission of
infectious diseases such as COVID-19. When performing aerosol-producing procedures during the pandemic of novel coronavirus,
every patient should be considered suspicious.
Keywords:
Keywords :
Electroconvulsive Therapy , COVID-19 , Suicide , SARS-CoV-2
